January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
iLeukon Therapeutics
Clinical stage company aimed at developing best-in-class IL-2 based therapy for the treatments of cancer, autoimmune diseases, and neurodegenerative diseases. Our assets were developed with proprietary mRNA technology and protein-engineering technologies.